home / stock / crsp / crsp articles

CRSP Articles, CRISPR Therapeutics AG - From 11/17/23

Stock Information
Company Name: CRISPR Therapeutics AG
Stock Symbol: CRSP
Market: NASDAQ
Website: crisprtx.com
Menu
CRSP CRSP Quote CRSP Short CRSP News CRSP Articles CRSP Message Board
Get CRSP Alerts

News, Short Squeeze, Breakout and More Instantly...
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday. Shares of Ross Stores, Inc. (NASDAQ: ROST) surged during Frid...
What's Going On With Crispr Therapeutics Stock Thursday? | Benzinga

CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/C...

UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia | Benzinga

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorization for Casgevy (exagamglogene auto...

Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results. Palo Alto Networks reported qu...
What's Going On With CRISPR Therapeutics Stock? | Benzinga

CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading lower Monday after Morgan Stanley maintained the company with an Underweight rating and lo...

Why CRISPR Therapeutics Stock Is Moving Higher Monday | Benzinga

CRISPR Therapeutics AG (NYSE: CRSP) shares are trading higher Monday after the company announced preclinical data for its investigational prog...

CRISPR Therapeutics Announces Preclinical Data at the American Heart Association (AHA) Scientific Sessions 2023 | Benzinga

-CTX310™ led to durable reductions of angiopoietin-like 3 protein (ANGPTL3) and triglyceride levels in non-human primates (NHPs) after a si...
AMD, CRISPR Therapeutics, Paycom Software, DraftKings, Tesla: Why These 5 Stocks Are On Investors' Radars Today | Benzinga

Major U.S. indices ended in the green on Tuesday, with the Dow gaining nearly 124 points or 0.4% to 33,052.87. The S&P 500 and the Nasdaq indic...

Questions Surround Vertex/CRISPR's Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches | Benzinga

The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will meet next week, Tuesday, 31 October, to discuss whether V...

Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On? | Benzinga

On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling over $6.5 million worth of Tesla Inc (NASDAQ:TSLA) shares. This sale come...
Previous 10 Next 10